Brief: Dermapharm H1 Adjusted EBITDA EUR 148 Million

Dermapharm Holding SE

12/08/2025 06:34

Aug 12 (Reuters) - DERMAPHARM HOLDING SE DMPG.DE:

H1 EBITDA MARGIN 25.2%

H1 ADJUSTED EBITDA MARGIN 25.8%

H1 EBITDA EUR 144.9 MILLION

H1 ADJUSTED EBITDA EUR 148 MILLION

H1 REVENUE EUR 574.5 MILLION

OUTLOOK 2025: BOARD OF MANAGEMENT CONFIRMS FULL-YEAR GUIDANCE FOR 2025

Source text: ID:nEQbQRzDra

Further company coverage: DMPG.DE

 (Gdansk Newsroom)

 ((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));))